suma/triglyceride

FIELD OF THE INVENTION The present invention relates to a novel thermoplastic elastomer composition and methods of making and using them in various applications. In particular, the present invention relates to successful application of reversible addition-fragmentation chain transfer polymerization

FIELD OF THE INVENTION The present invention relates to a novel thermoplastic elastomer composition and methods of making and using them in various applications. In particular, the present invention relates to successful application of reversible addition-fragmentation chain transfer polymerization

INTRODUCTION In his U.S. Pat. No. 6,602,909 the author claimed that supplementation of dietary proteins with L-Tryptophan (80 mgs.), L-Methionine (90 mgs.) L-Valine (103 mgs.) and L-Lysine Monohydrochloride (128 mgs.) would lower peak postprandial blood glucose levels and reduce urea formation.

This invention relates to novel hypolipidemic compositions containing an active ingredient which lower plasma lipid concentrations and to a method of producing hypolipidemic activity by administering nontoxic effective quantities of said ingredient to hyperlipidemic subjects. More specifically, the

SUMMARY OF THE INVENTION Dodecapeptides of the formula: ##STR2## where X.sub.1 is either D- or L- Lys, Arg, His or Orn; X.sub.2 is either D- or L- Asn, His, Glu, Asp, Tyr or Trp; X.sub.3 is either D- or L- Trp; the linear precursor intermediates thereof and pharmaceutically acceptable salts and

FIELD OF THE INVENTION The present invention relates to methods of prevention, treatment or alleviation of cachexia and other wasting syndromes or conditions of loss of weight and/or muscle atrophy by modulation, including inhibition, of lipase, particularly adipose triglyceride lipase (ATGL). The

TECHNICAL FIELD This invention relates to olefin polymerization processes and particularly to the deactivation of alkylaluminum catalyst in hydrocarbon carriers to be recycled after use. Our invention is particularly useful for the deactivation of triethyl aluminum in hexane or heptane. A major

BACKGROUND OF THE INVENTION The invention relates to the new biphenylyl ethers of the general Formula I ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are each H or CH.sub.3 ; R.sup.4 is H, F, Cl, Br or CF.sub.3 ; Z (when R.sup.2 = R.sup.3 = H) is piperidino or morpholino each of which is

TECHNICAL FIELD The present invention relates to the area of foods and beverages, and in particular foods and beverages containing sucrose fatty acid esters. BACKGROUND OF THE INVENTION A number of references disclose food or beverage compositions made with sucrose fatty acid esters. For example,

Reference is hereby made to U.S. Ser. No. 015,394 filed Feb. 17, 1987, now U.S. Pat. No. 4,918,063. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to pharmaceutical compositions and methods for protecting the luminal lining of the gastrointestinal tract from

REFERENCE TO A SEQUENCE LISTING This application contains references to amino acid sequences and/or nucleic acid sequences which have been submitted concurrently herewith as the sequence listing text file "60941198.sub.--1.txt", file size 64 KiloBytes (KB), created on Mar. 29, 2012. The

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to binders based on homopolymers or copolymers of styrene, to their production and to their use for bonding, coating and sealing. Binders in the context of the invention are substances which are capable of bonding or firmly

FIELD OF THE INVENTION This invention relates to the 3'-(L-ascorbyl-2-o-phosphoryl)-cholesterol, 3'-(L-ascorbyl-3-o-phosphoryl)-cholesterol, and their derivatives (hereinafter collectively referred to as either "Ascorbyl-Phosphoryl-Cholesterol" or "APC compound(s)"). Specifically, this invention

FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions and methods for protecting the luminal lining of the gastrointestinal tract from ulceration. In particular, the present invention relates to compositions which include unique mixtures of phospholipids, triglycerides

BACKGROUND OF THE INVENTION The government may own certain rights in the present invention pursuant to NIH grant AM 33239. 1. Field of the Invention The present invention relates to pharmaceutical compositions and methods for protecting the luminal lining of the gastrointestinal tract from